160 related articles for article (PubMed ID: 11445797)
1. Nonadherence is associated with late rejection in pediatric heart transplant recipients.
Ringewald JM; Gidding SS; Crawford SE; Backer CL; Mavroudis C; Pahl E
J Pediatr; 2001 Jul; 139(1):75-8. PubMed ID: 11445797
[TBL] [Abstract][Full Text] [Related]
2. The importance of early cyclosporine levels in pediatric kidney transplantation.
Matas AJ; Gillingham KJ; Chavers BM; Nevins T; Kashtan C; Mauer SM; Payne WD; Gruessner R; Najarian JS
Clin Transplant; 1996 Dec; 10(6 Pt 1):482-6. PubMed ID: 8996767
[TBL] [Abstract][Full Text] [Related]
3. Association of parental pretransplant psychosocial assessment with post-transplant morbidity in pediatric heart transplant recipients.
Stone D; Banerjee M; Dupuis J; Leleszi J; Allasio D; Singh TP
Pediatr Transplant; 2006 Aug; 10(5):602-7. PubMed ID: 16856997
[TBL] [Abstract][Full Text] [Related]
4. An objective measure to identify pediatric liver transplant recipients at risk for late allograft rejection related to non-adherence.
Venkat VL; Nick TG; Wang Y; Bucuvalas JC
Pediatr Transplant; 2008 Feb; 12(1):67-72. PubMed ID: 18186891
[TBL] [Abstract][Full Text] [Related]
5. Advantages of C2 monitoring to avoid acute rejection in pediatric heart transplant recipients.
Schubert S; Abdul-Khaliq H; Lehmkuhl HB; Hübler M; Abd El Rahman MY; Miera O; Ewert P; Weng Y; Wei H; Krüdewagen B; Hetzer R; Berger F
J Heart Lung Transplant; 2006 Jun; 25(6):619-25. PubMed ID: 16730566
[TBL] [Abstract][Full Text] [Related]
6. Socioeconomic position and graft failure in pediatric heart transplant recipients.
Singh TP; Gauvreau K; Bastardi HJ; Blume ED; Mayer JE
Circ Heart Fail; 2009 May; 2(3):160-5. PubMed ID: 19808335
[TBL] [Abstract][Full Text] [Related]
7. Relationship between pharmacokinetic parameters of cyclosporin and the incidence of acute rejection after heart transplantation.
Aumente MD; Arizón JM; Segura J; López A; Albornoz R; Cárdenas M; Segura C
Transplant Proc; 2005 Nov; 37(9):4014-7. PubMed ID: 16386613
[TBL] [Abstract][Full Text] [Related]
8. Late acute cardiac allograft rejection: new therapeutic options?
Schweiger M; Wasler A; Prenner G; Tripolt M; Schwarz M; Tscheliessnigg KH
Transplant Proc; 2005 Dec; 37(10):4528-31. PubMed ID: 16387161
[TBL] [Abstract][Full Text] [Related]
9. Outcome of heart transplants 15 to 20 years ago: graft survival, post-transplant morbidity, and risk factors for mortality.
Roussel JC; Baron O; Périgaud C; Bizouarn P; Pattier S; Habash O; Mugniot A; Petit T; Michaud JL; Heymann MF; Treilhaud M; Trochu JN; Gueffet JP; Lamirault G; Duveau D; Despins P
J Heart Lung Transplant; 2008 May; 27(5):486-93. PubMed ID: 18442713
[TBL] [Abstract][Full Text] [Related]
10. Late complications in pediatric cardiac transplant recipients.
Addonizio LJ; Hsu DT; Smith CR; Gersony WM; Rose EA
Circulation; 1990 Nov; 82(5 Suppl):IV295-301. PubMed ID: 2225419
[TBL] [Abstract][Full Text] [Related]
11. The natural history of renal function following orthotopic heart transplant.
Al Aly Z; Abbas S; Moore E; Diallo O; Hauptman PJ; Bastani B
Clin Transplant; 2005 Oct; 19(5):683-9. PubMed ID: 16146562
[TBL] [Abstract][Full Text] [Related]
12. Genetic polymorphisms impact the risk of acute rejection in pediatric heart transplantation: a multi-institutional study.
Girnita DM; Brooks MM; Webber SA; Burckart GJ; Ferrell R; Zdanowicz G; DeCroo S; Smith L; Chinnock R; Canter C; Addonizio L; Bernstein D; Kirklin JK; Ranganathan S; Naftel D; Girnita AL; Zeevi A
Transplantation; 2008 Jun; 85(11):1632-9. PubMed ID: 18551071
[TBL] [Abstract][Full Text] [Related]
13. Late acute rejection and subclinical noncompliance with cyclosporine therapy in heart transplant recipients.
De Geest S; Abraham I; Moons P; Vandeputte M; Van Cleemput J; Evers G; Daenen W; Vanhaecke J
J Heart Lung Transplant; 1998 Sep; 17(9):854-63. PubMed ID: 9773856
[TBL] [Abstract][Full Text] [Related]
14. Cause of death in pediatric and infant heart transplant recipients: review of a 20-year, single-institution cohort.
Zuppan CW; Wells LM; Kerstetter JC; Johnston JK; Bailey LL; Chinnock RE
J Heart Lung Transplant; 2009 Jun; 28(6):579-84. PubMed ID: 19481018
[TBL] [Abstract][Full Text] [Related]
15. Limitations of cyclosporine C2 monitoring in pediatric heart transplant recipients.
Hmiel SP; Canter C; Shepherd R; Lassa-Claxton S; Nadler M
Pediatr Transplant; 2007 Aug; 11(5):524-9. PubMed ID: 17631021
[TBL] [Abstract][Full Text] [Related]
16. Effect of late medication non-compliance on outcome after heart transplantation: a 5-year follow-up.
Dobbels F; De Geest S; van Cleemput J; Droogne W; Vanhaecke J
J Heart Lung Transplant; 2004 Nov; 23(11):1245-51. PubMed ID: 15539122
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of tacrolimus compared with cyclosporin A microemulsion in renal transplantation: 2 year follow-up results.
Krämer BK; Montagnino G; Del Castillo D; Margreiter R; Sperschneider H; Olbricht CJ; Krüger B; Ortuño J; Köhler H; Kunzendorf U; Stummvoll HK; Tabernero JM; Mühlbacher F; Rivero M; Arias M;
Nephrol Dial Transplant; 2005 May; 20(5):968-73. PubMed ID: 15741208
[TBL] [Abstract][Full Text] [Related]
18. Survival, graft atherosclerosis, and rejection incidence in heart transplant recipients treated with statins: 5-year follow-up.
Stojanovic I; Vrtovec B; Radovancevic B; Radovancevic R; Yazdanbakhsh AP; Thomas CD; Frazier OH
J Heart Lung Transplant; 2005 Sep; 24(9):1235-8. PubMed ID: 16143239
[TBL] [Abstract][Full Text] [Related]
19. Everolimus and reduced cyclosporine trough levels in maintenance heart transplant recipients.
Schweiger M; Wasler A; Prenner G; Stiegler P; Stadlbauer V; Schwarz M; Tscheliessnigg K
Transpl Immunol; 2006 Jun; 16(1):46-51. PubMed ID: 16701176
[TBL] [Abstract][Full Text] [Related]
20. Complete immunosuppressive withdrawal as a uniform approach to post-transplant lymphoproliferative disease in pediatric liver transplantation.
Hurwitz M; Desai DM; Cox KL; Berquist WE; Esquivel CO; Millan MT
Pediatr Transplant; 2004 Jun; 8(3):267-72. PubMed ID: 15176965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
